Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€57.23

€57.23

1.010%
0.57
1.010%
€69.18
 
11.06.25 / Tradegate WKN: 859034 / Symbol: CVS / Name: CVS Health / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:

CVS Health Corp. Stock

CVS Health Corp. gained 1.010% today.
The stock is an absolute favorite of our community with 37 Buy predictions and no Sell predictions.
As a result the target price of 69 € shows a positive potential of 20.57% compared to the current price of 57.23 € for CVS Health Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for CVS Health Corp. stock. Negative votes have not been in the majority for any criteria for this stock

CVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.

Pros and Cons of CVS Health Corp. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of CVS Health Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
CVS Health Corp. 1.010% 2.728% -3.799% 2.434% 34.611% -35.392% 2.379%
Walgreens Boots Alliance Inc. -0.820% 0.010% -1.042% -33.378% 6.848% -74.991% -72.616%
McKesson Corp. 0.420% 0.418% 1.396% 13.481% 13.564% 109.738% 339.241%
Cardinal Health Inc. -0.260% -0.963% 1.519% 45.011% 18.214% 163.085% 187.682%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-31

In general, the financials of CVS Health, a major player in the Food & Drug Retailing industry, appear to be stable and relatively strong. The company has shown a steady growth in total assets and revenues over the past few years. However, it is crucial to dig deeper into the financial statements to identify the underlying strengths and potential areas of concern for the company.

Growth in Total Assets and Revenues: CVS Health's total assets and revenues have experienced positive growth from 2020 to 2022. In 2020, the company's total assets were at €230.71 billion, and total revenues were at €268.71 billion. By 2022, these numbers increased to $228.28 billion and $322.47 billion, respectively. This indicates that CVS is continuously expanding its business operations and generating higher sales.

Increasing Gross Profit: CVS Health's gross profit has also seen consistent growth from €49.05 billion in 2020 to $54.29 billion in 2022. This reveals the company's ability to maintain its cost of revenue and increase overall profitability from its core operations.

Comments

Prediction Buy
Perf. (%) 3.23%
Target price 69.481
Change
Ends at 02.06.26

CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Barclays PLC from $82.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.99%
Target price 74.827
Change
Ends at 12.05.26

CVS Health Co. (NYSE: CVS) had its price target raised by analysts at Truist Financial Co. from $82.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
Show more

CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company.
Ratings data for CVS provided by MarketBeat
Show more

News

CVS Health Stock: Shares Surge on Q1 Earnings Beat
CVS Health Stock: Shares Surge on Q1 Earnings Beat

CVS Health has delivered impressive first-quarter results for 2025, significantly exceeding market expectations and triggering a substantial stock rally. The healthcare giant reported a 7.0% revenue

CVS Health Stock: Leadership Changes Boost Market Position
CVS Health Stock: Leadership Changes Boost Market Position

CVS Health stock has demonstrated remarkable resilience in an uncertain market environment, recently breaking through the $69 mark before settling at $66.56. This upward momentum comes amid

CVS Health Stock: Divestiture Strengthens Strategic Focus
CVS Health Stock: Divestiture Strengthens Strategic Focus

CVS Health has completed the divestiture of its Medicare Shared Savings Program business to Wellvana in an all-stock transaction. This strategic move grants CVS Health a minority stake in Wellvana